BioMarin Pharmaceutical Inc. (BVMF:B1MR34)
Brazil
· Delayed Price · Currency is BRL 143.56
+1.73 (1.22%)
At close: Dec 5, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 55.53 billion as of December 5, 2025. Its market cap has decreased by -18.47% in one year.
Market Cap
55.53B
Enterprise Value
50.80B
Revenue
16.49B
Ranking
n/a
PE Ratio
20.02
Stock Price
143.56
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 813.63M to 55.53B, an increase of 6,724.67%. That is a compound annual growth rate of 17.36%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.37B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.38B |